查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
治疗用呼吸系统设备的世界市场规模:各产品，各用途，各最终用途，产业分析，地区预测，成长可能性，COVID-19影响的分析，竞争市场占有率与预测(2022年～2030年)
市场调查报告书
商品编码
1132583

治疗用呼吸系统设备的世界市场规模:各产品，各用途，各最终用途，产业分析，地区预测，成长可能性，COVID-19影响的分析，竞争市场占有率与预测(2022年～2030年)

Therapeutic Respiratory Devices Market Size By Product, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
出版日期: | 出版商: Global Market Insights Inc. | 英文 330 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球治疗用呼吸系统设备市场，预计至2030年记录大幅度的成长。产业的扩大，起因于免疫力低可能容易有呼吸系统问题的老年人口增加。

本报告提供全球治疗用呼吸系统设备市场相关调查分析，产业的考察，市场区隔分析，地区分析，竞争情形等资讯。

目录

第1章 调查手法和范围

第2章 摘要整理

第3章 治疗用呼吸系统设备产业的考察

  • 产业市场区隔
  • 产业形势(2017年～2030年)
  • 产业的影响要素
    • 成长促进因素
    • 产业的潜在的风险、课题
  • 成长可能性分析
    • 各产品
    • 各用途
    • 各最终用途
  • 技术形势
  • 法规形势
    • 美国
    • 欧洲
  • COVID-19影响的分析
  • 波特的五力分析
  • 竞争情形(2021年)
    • 企业矩阵分析(2021年)
  • 大环境分析

第4章 治疗用呼吸系统设备市场:各产品

  • 主要的市场区隔趋势
  • 阳压呼吸器(PAP)设备
    • 市场规模:各地区(2017年～2030年)
    • 持续性阳压呼吸器(CPAP)设备
    • 自动滴定阳压呼吸器(APAP)设备
    • 双阶阳压呼吸器(BiPAP)设备
  • 氧气浓缩机
    • 市场规模:各地区(2017年～2030年)
    • 固定式氧气浓缩机
    • 便携式氧气浓缩机
  • 人工呼吸器
    • 市场规模:各地区(2017年～2030年)
    • 成人用人工呼吸器
    • 新生儿用人工呼吸器
  • 吸入器
    • 市场规模:各地区(2017年～2030年)
    • 定量喷雾吸入器(MDI)
    • 干粉吸入剂(DPI)
    • 缓雾吸入器(SMI)
  • 喷雾器
    • 市场规模:各地区(2017年～2030年)
    • 压缩机式喷雾器
    • 活塞式手持喷雾器
    • 超音波式喷雾器
  • 加湿器
    • 市场规模:各地区(2017年～2030年)
    • 加温加湿器
    • 通行证外套型加湿器
    • 一体型加湿器
    • 内装加湿器
    • 独立加湿器
  • 其他

第5章 治疗用呼吸系统设备市场:各用途

  • 主要的市场区隔趋势
  • COPD
  • 阻塞型睡眠呼吸中止症
  • 气喘
  • 呼吸窘迫症候群
  • 囊状纤维化症
  • 其他

第6章 治疗用呼吸系统设备市场:各最终用途

  • 主要的市场区隔趋势
  • 医院
  • 居家照护环境
  • 急救中心

第7章 治疗用呼吸系统设备市场:各地区

  • 主要地区趋势
  • 北美
    • 市场规模:各国(2017年～2030年)
    • 市场规模:各产品(2017年～2030年)
    • 市场规模:各用途(2017年～2030年)
    • 市场规模:各最终用途(2017年～2030年)
    • 美国
    • 加拿大
  • 欧洲
    • 市场规模:各国(2017年～2030年)
    • 市场规模:各产品(2017年～2030年)
    • 市场规模:各用途(2017年～2030年)
    • 市场规模:各最终用途(2017年～2030年)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 市场规模:各国(2017年～2030年)
    • 市场规模:各产品(2017年～2030年)
    • 市场规模:各用途(2017年～2030年)
    • 市场规模:各最终用途(2017年～2030年)
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 南美
    • 市场规模:各国(2017年～2030年)
    • 市场规模:各产品(2017年～2030年)
    • 市场规模:各用途(2017年～2030年)
    • 市场规模:各最终用途(2017年～2030年)
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东、非洲
    • 市场规模:各国(2017年～2030年)
    • 市场规模:各产品(2017年～2030年)
    • 市场规模:各用途(2017年～2030年)
    • 市场规模:各最终用途(2017年～2030年)
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国

第8章 企业简介

  • 竞争仪表板(2021年)
  • Breas Medical AB
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Hamilton Medical
  • Hill-Rom Services Inc. (Baxter)
  • ICU Medical, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • VYAIRE MEDICAL, INC.
简介目录
Product Code: 696

The global therapeutic respiratory devices market is anticipated to register considerable growth through 2030. The industry expansion can be attributed to the rising elderly population which is prone to respiratory problems due to weakened immune systems. To that end, the instances of respiratory-related infections have also risen, leading to lung cancer, COPD, and asthma. The high rate of respiratory deaths is likely to drive product sales in the projected timeline. Also, the availability of advanced medical devices to minimize the severity of every person's medical condition will foster market growth.

The high costs associated with the treatment of respiratory diseases may be a key factor hindering the industry expansion. As per a study, asthma results in approximately 500,000 deaths annually and over 1,300 deaths daily. Rising caseloads of respiratory diseases and increased intensity of illness have raised treatment costs. Eventually, it increases the burden on healthcare units due to direct and indirect expenses.

Based on product, the industry is segmented into positive airway pressure (PAP) devices, oxygen concentrators, ventilators, inhalers, humidifiers, and nebulizers. The ventilators segment registered over USD 4 billion in 2021, owing to technological advancements in product design and the surge in the geriatric population. Additionally, improved capabilities of ventilation technologies for lung injury prevention and fewer treatment times are likely to foster the growth of the segment.

On the basis of application, the industry is classified into COPD, asthma, obstructive sleep apnea, cystic fibrosis, and respiratory distress syndrome. The asthma segment held over 28% market share in 2021, owing to the introduction of advanced medications including inhalers and nebulizers. According to the data from the Asthma and Allergy Foundation of America, nearly 25 million people are susceptible to asthma in the U.S., which is equivalent to 1 in 13 people. Additionally, the average mortality from asthma is 11 in the U.S. daily. In 2020, 4,145 patients died of asthma, which increases the need for advanced asthma medications.

Based on end-use, the industry is categorized into hospitals, homecare settings, and emergency centers. The industry size from the homecare settings segment is flourishing at a considerable rate, owing to the adoption of improved treatment procedures that require minimal intervention from doctors. In addition, the increased psychological comfort and favorable environment facilitate the patient.

On the regional front, the industry is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Latin America is expected to grow at over 4% CAGR, owing to the increased instances of respiratory problems in the region. Additionally, the adoption of the latest treatment modules for treating such ailments is likely to foster product sales in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Therapeutic respiratory devices industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Therapeutic Respiratory Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of respiratory diseases in developing countries
      • 3.3.1.2 Increasing geriatric population globally
      • 3.3.1.3 Technological innovation in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Lack of patient compliance
      • 3.3.2.2 Cost burden of respiratory diseases
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 Technology landscape
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 COVID- 19 impact analysis
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
    • 3.9.1 Company matrix analysis, 2021
  • 3.10 PESTLE analysis

Chapter 4 Therapeutic Respiratory Devices Market, By Product

  • 4.1 Key segment trends
  • 4.2 Positive Airway Pressure (PAP) devices
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 Continuous positive airway pressure (CPAP) devices
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Auto-titrating positive airway pressure (APAP) devices
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.4 Bi-level positive airway pressure (BiPAP) devices
      • 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Oxygen concentrators
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.2 Fixed oxygen concentrators
      • 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.3 Portable oxygen concentrators
      • 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Ventilators
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.2 Adult ventilators
      • 4.4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.3 Neonatal ventilators
      • 4.4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.5 Inhalers
    • 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.2 Metered dose inhaler (MDI)
      • 4.5.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.3 Dry powder inhaler (DPI)
      • 4.5.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.4 Soft mist inhaler (SMI)
      • 4.5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.6 Nebulizers
    • 4.6.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.2 Compressor-based nebulizers
      • 4.6.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.3 Piston-based hand-held nebulizers
      • 4.6.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.4 Ultrasonic nebulizers
      • 4.6.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.7 Humidifiers
    • 4.7.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.2 Heated humidifiers
      • 4.7.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.3 Passover humidifiers
      • 4.7.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.4 Integrated humidifiers
      • 4.7.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.5 Built-in humidifiers
      • 4.7.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.6 Standalone humidifiers
      • 4.7.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Therapeutic Respiratory Devices Market, By Application

  • 5.1 Key segment trends
  • 5.2 COPD
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Obstructive sleep apnea
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Asthma
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Respiratory distress syndrome
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Cystic fibrosis
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Therapeutic Respiratory Devices Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Homecare settings
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Emergency centers
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Therapeutic Respiratory Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.2.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.2.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.2.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.2.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.2.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.2.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.3.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.3.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.3.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.3.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.3.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.3.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.4.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.4.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.4.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.4.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.4.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.4.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.5.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.5.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.5.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.5.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.5.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.5.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.6.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.6.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.6.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.6.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.6.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.6.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2021
  • 8.2 Breas Medical AB
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 Swot analysis
  • 8.3 Dragerwerk AG & Co. KGaA
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 Swot analysis
  • 8.4 Fisher & Paykel Healthcare Limited
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 Swot analysis
  • 8.5 GE Healthcare
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 Swot analysis
  • 8.6 Hamilton Medical
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 Swot analysis
  • 8.7 Hill-Rom Services Inc. (Baxter)
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 Swot analysis
  • 8.8 ICU Medical, Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 Swot analysis
  • 8.9 Invacare Corporation
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 Swot analysis
  • 8.10 Koninklijke Philips N.V.
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 Swot analysis
  • 8.11 Medtronic
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 Swot analysis
  • 8.12 ResMed
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 Swot analysis
  • 8.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 Swot analysis
  • 8.14 VYAIRE MEDICAL, INC.
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 Swot analysis